Skip to main content
HeartCited

Lycopene High Blood Pressure (Hypertension)

B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。

Meta-analysis of 6 RCTs: systolic -5.6 mmHg. Improved endothelial function. Cooking with oil enhances absorption 2-3x. Strong observational associations with lower MI risk.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dlycopene\u0026condition\u003Dhigh\u002Dblood\u002Dpressure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Meta-analysis of 6 RCTs: systolic -5.6 mmHg. Improved endothelial function. Cooking with oil enhances absorption 2-3x. Strong observational associations with lower MI risk.

Key Study Findings

Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily vs: Placebo Outcome: Preeclampsia risk reduction 効果: ~50% risk reduction None

対象集団: Pregnant women with low calcium intake

Randomized Controlled Trial n=442 156 weeks Open-label
Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention …
Dose: None vs: Usual diet Outcome: 3-year change in global cognitive function (composite) 効果: β=0.17 SU per unit carotenoid (APOE ε4) 0.009

対象集団: Older adults ≥65y, BMI>25, family history of AD, MoCA≥22

Meta-Analysis
Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis.
Dose: None vs: Placebo Outcome: Blood pressure 効果: None None

対象集団: None

Key Statistics

6

研究数

400

参加者数

Positive

B

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
6-15 mg/day
cardiovascularsupport:
15-30 mg/day

上限量: Not formally established; up to 75 mg/day used in clinical trials

研究で検討された用量

用量 期間 効果 N
500 mg daily -- Positive --
None 156 weeks Positive 442
None -- Neutral --

推奨摂取タイミング: With meals containing fat (cooking with olive oil enhances absorption 2-3x)

Safety & Side Effects

報告されている副作用

  • Generally well-tolerated
  • Lycopenodermia (orange skin discoloration) at very high intake — harmless and reversible

既知の相互作用

  • Blood pressure medications (may have mild additive effect)
  • Beta-carotene (may compete for absorption)

耐容上限摂取量: Not formally established; up to 75 mg/day used in clinical trials

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Lycopene help with High Blood Pressure (Hypertension)?
Based on 6 studies with 400 participants, there is moderate evidence from clinical studies that Lycopene may support High Blood Pressure (Hypertension) management. Our evidence grade is B (Good Evidence).
How much Lycopene should I take for High Blood Pressure (Hypertension)?
Studies have used various dosages. A commonly studied range is 6-15 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lycopene?
Reported side effects may include Generally well-tolerated, Lycopenodermia (orange skin discoloration) at very high intake — harmless and reversible. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lycopene and High Blood Pressure (Hypertension)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Lycopene 他の症状・状態について

References

  1. [1] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
  2. [2] Xiaoran Liu et al.. Am J Clin Nutr. 2025. Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled … doi:10.1016/j.ajcnut.2025.08.012 PubMed
  3. [3] Sitong Wan et al.. Nutrients. 2024. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. doi:10.3390/nu16142213 PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。